Flamel Technologies SA (FLML.OQ)

FLML.OQ

About

Flamel Technologies S.A. (Flamel) is a biopharmaceutical company. Flamel is engaged in the development and licensing of two polymer-based drug delivery technologies. Its drug delivery technology business is built primarily on two technologies: Medusa and Micropump. Its hydrogel Medusa technology is designed to provide controlled... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.72
Market Cap (Mil.):	$118.18
Shares Outstanding (Mil.):	25.42
Dividend:	--
Yield (%):	--

Financials

	FLML.OQ	Industry	Sector
P/E (TTM):	--	53.78	35.83
EPS (TTM):	-0.57	--	--
ROI:	--	1.00	18.72
ROE:	--	2.10	19.54

Latest News about FLML.OQ

» More FLML.OQ News

Competitors

	Price	Change
Covidien plc (COV.N)	$65.77	+0.10
Hi-Tech Pharmacal Co. (HITK.OQ)	$32.27	+0.83
Depomed Inc (DEPO.OQ)	$5.48	+0.08
Human Genome Sciences (HGSI.OQ)	--	--
Nektar Therapeutics (NKTR.OQ)	$9.79	+0.19
SkyePharma PLC (SKP.L)	43.50p	-1.75
Enzon Pharmaceuticals Inc (ENZN.OQ)	$3.17	-0.01
DURECT Corporation (DRRX.OQ)	$0.89	-0.09
Pain Therapeutics, Inc. (PTIE.OQ)	$2.89	+0.09

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
FLAMEL TECHNOLOGIES SA (FLML) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
Flamel Technologies SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Thomson Reuters Stock Report - FLAMEL TECHNOLOGIES S.A. (FLML-O) Provider: Thomson Reuters Stock Report	$25.00 Buy
Flamel Technologies ADR Provider: S&P Capital IQ Quantitative Report	$58.00 Buy
Flamel Technologies S.A. (FLML) - Financial and Strategic SWOT Analysis Review Provider: GlobalData	$125.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.